Responses
Rheumatoid arthritis
Original research
Long-term safety and efficacy of sirukumab for patients with rheumatoid arthritis who previously received sirukumab in randomised controlled trials (SIRROUND-LTE)
Compose a Response to This Article
Other responses
No responses have been published for this article.